JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB32077

Anti-EGFR 抗体 [E235]

Anti-EGFR antibody [E235]

  • BOND RX™ Validated
  • KO Validated
  • RabMAb
  • Recombinant
  • Lab Essentials
  • 20ul selling size
  • 了解详情

5

(4 Reviews)

|

(34 Publications)

Anti-EGFR antibody [E235] (ab32077) is a rabbit monoclonal antibody detecting EGFR in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IP, IHC-P, ICC/IF. Suitable for Human, Mouse, Rat.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 30 publications
- Trusted since 2006

查看别名

ERBB, ERBB1, HER1, EGFR, Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1

10 Images
Western blot - Anti-EGFR antibody [E235] (AB32077)
  • WB

Supplier Data

Western blot - Anti-EGFR antibody [E235] (AB32077)

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.

In Western blot, Anti-EGFR antibody - Total protein control (ab32077) staining at 1/1000 dilution.

All lanes:

Western blot - Anti-EGFR (phospho Y1045) antibody [EPR28381-88] (<a href='/products/primary-antibodies/egfr-phospho-y1045-antibody-epr28381-88-ab316155'>ab316155</a>) at 1/1000 dilution

Lane 1:

Untreated A431 (human epidermoid carcinoma epithelial cell) whole cell lysate (untreated membrane) at 20 µg

Lane 2:

A431 treated with 100 ng/ml EGF for 30 minutes whole cell lysate (untreated membrane) at 20 µg

Lane 3:

A431 treated with 100 ng/ml EGF for 30 minutes whole cell lysate (alkaline phosphatase treated membrane) at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Observed band size: 175 kDa,36 kDa

false

Exposure time: 10s

Western blot - Anti-EGFR antibody [E235] (AB32077)
  • WB

Supplier Data

Western blot - Anti-EGFR antibody [E235] (AB32077)

In Western blot, ab316155 was shown to bind specifically to EGFR (phospho Y1045). Target of interest was observed at 175 kDa in wild-type HeLa cell lysates (lane 2) with no signal observed at this size in EGFR knockout cell line (lanes 3-4 KO cell line ab255385/KO cell lysate ab263845).

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.

In Western blot, Anti-EGFR antibody (ab32077) staining at 1/1000 dilution.

All lanes:

Western blot - Anti-EGFR (phospho Y1045) antibody [EPR28381-88] (<a href='/products/primary-antibodies/egfr-phospho-y1045-antibody-epr28381-88-ab316155'>ab316155</a>) at 1/1000 dilution

Lane 1:

Untreated Wild-type HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg

Lane 2:

Wild-type HeLa treated with 100 ng/ml EGF for 30 minutes whole cell lysate at 20 µg

Lane 3:

Untreated EGFR knockout HeLa whole cell lysate at 20 µg

Lane 4:

EGFR knockout HeLa treated with 100 ng/ml EGF for 30 minutes whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Observed band size: 175 kDa,36 kDa

false

Exposure time: 180s

Western blot - Anti-EGFR antibody [E235] (AB32077)
  • WB

Lab

Western blot - Anti-EGFR antibody [E235] (AB32077)

Western blot : Anti-EGFR antibody [E235] (ab32077) staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab32077 was shown to bind specifically to EGFR. A band was observed at 160 kDa in wild-type cell lysates with no signal observed at this size in EGFR knockout cell lines. To generate this image, wild-type and EGFR knockout A549 (ab286394) and HeLa (ab255385) cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3% milk in TBS-0.1% Tween ® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-EGFR antibody [E235] (ab32077) at 1/1000 dilution

Lane 1:

Wild-type A549 cell lysate at 20 µg

Lane 2:

Western blot - Human EGFR knockout A549 cell line (<a href='/products/cell-lines/human-egfr-knockout-a549-cell-line-ab286394'>ab286394</a>)

Lane 2:

EGFR knockout A549 cell lysate at 20 µg

Lanes 2 and 4:

Western blot - Human EGFR knockout HeLa cell line (<a href='/products/cell-lines/human-egfr-knockout-hela-cell-line-ab255385'>ab255385</a>)

Lane 3:

Wild-type HeLa cell lysate at 20 µg

Lane 4:

EGFR knockout HeLa cell lysate at 20 µg

Observed band size: 160 kDa

false

Western blot - Anti-EGFR antibody [E235] (AB32077)
  • WB

Lab

Western blot - Anti-EGFR antibody [E235] (AB32077)

This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour before being incubated with ab32077 overnight at 4°C in the presence of loading control ab18058 (Mouse monoclonal [SPM227] to Vinculin diluted 1 : 10000). Antibody binding was detected using IR-labelled goat anti-Rabbit Ab at a 1 : 10,000 dilution for one hour at room temperature before imaging.

This product yielded a strong signal in western blot using A431 (human squamous carcinoma) lysate which naturally overexpresses the EGFR protein. Western blot conditions may need to be optimised for cell lines and tissues that express lower levels of endogenous EGFR.

All lanes:

Western blot - Anti-EGFR antibody [E235] (ab32077) at 1/1000 dilution

Lane 1:

Caco-2 cell lysate at 20 µg

Lane 2:

A431 cell lysate at 20 µg

Lane 3:

Mouse skin cell lysate at 20 µg

Lane 4:

Rat skin cell lysate at 20 µg

Predicted band size: 134 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EGFR antibody [E235] (AB32077)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EGFR antibody [E235] (AB32077)

IHC image of EGFR staining in a formalin fixed, paraffin embedded mouse normal skin tissue section, performed on a Leica Bond™ system using the standard protocol B. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab32077 at 1/200 dilution for 15 mins at room temperature. A goat anti-rabbit biotinylated secondary antibody was used to detect the primary, and visualized using an HRP conjugated ABC system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Flow Cytometry (Intracellular) - Anti-EGFR antibody [E235] (AB32077)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-EGFR antibody [E235] (AB32077)

Overlay histogram showing A431 cells stained with ab32077 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab32077, 1/1000 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (0.1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter.

Immunocytochemistry/ Immunofluorescence - Anti-EGFR antibody [E235] (AB32077)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-EGFR antibody [E235] (AB32077)

Immunocytochemistry/Immunofluorescence analysis of A431 cells labelling EGFR with ab32077 at 1/500. Cells were fixed with 100% methanol. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody.
Control : PBS only.
Nuclear counter stain : DAPI.

Immunoprecipitation - Anti-EGFR antibody [E235] (AB32077)
  • IP

Unknown

Immunoprecipitation - Anti-EGFR antibody [E235] (AB32077)

Purified ab32077 at 1/50 dilution (2μg) immunoprecipitating EGFR in A431 whole cell lysate.
Lane 1 (input) : A431 (Human epidermoid carcinoma epithelial cell) whole cell lysate 10μg
Lane 2 (+) : ab32077 + A431 whole cell lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab32077 in A431 whole cell lysate.
VeriBlot for IP Detection Reagent (HRP) (ab131366) (1/1000 dilution) was used for Western blotting.
Blocking Buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM/TBST.
Observed band size : 180 kDa

All lanes:

Immunoprecipitation - Anti-EGFR antibody [E235] (ab32077)

Predicted band size: 134 kDa

false

Western blot - Anti-EGFR antibody [E235] (AB32077)
  • WB

Lab

Western blot - Anti-EGFR antibody [E235] (AB32077)

False colour image of Western blot : Anti-EGFR antibody [E235] staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab32077 was shown to bind specifically to EGFR. A band was observed at 180 kDa in wild-type HCT 116 cell lysates with no signal observed at this size in Egfr knockout cell line ab281597 (knockout cell lysate ab282949). To generate this image, wild-type and Egfr knockout HCT 116 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-EGFR antibody [E235] (ab32077) at 1/1000 dilution

Lane 1:

Wild-type HCT 116 cell lysate at 20 µg

Lane 2:

EGFR knockout HCT 116 cell lysate at 20 µg

Lane 2:

Western blot - Human EGFR knockout HCT116 cell line (<a href='/products/cell-lines/human-egfr-knockout-hct116-cell-line-ab281597'>ab281597</a>)

Lane 3:

HeLa cell lysate at 20 µg

Lane 4:

Caco-2 cell lysate at 20 µg

Predicted band size: 134 kDa

Observed band size: 180 kDa

true

Western blot - Anti-EGFR antibody [E235] (AB32077)
  • WB

Lab

Western blot - Anti-EGFR antibody [E235] (AB32077)

** Lanes 1 - 4 : ** Merged signal (red and green). Green - ab32077 observed at 175 kDa. Red - loading control, ab130007 observed at 125 kDa. ab32077 was shown to react with EGFR in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab255385 (knockout cell lysate ab263845) was used. Wild-type and EGFR knockout samples were subjected to SDS-PAGE. ab32077 and Anti-Vinculin antibody [VIN-54] (ab130007) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-EGFR antibody [E235] (ab32077) at 1/1000 dilution

Lane 1:

A431 cell lysate at 20 µg

Lane 2:

MDA-MB-468 cell lysate at 20 µg

Lane 3:

Wild type HeLa cell lysate at 20 µg

Lane 4:

EGFR knockout HeLa cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/20000 dilution

Predicted band size: 134 kDa

Observed band size: 124 kDa,134 kDa

false

不同偶联物与剂型 (10)

关键信息

宿主种属

Rabbit

克隆

Monoclonal

克隆号

E235

亚型

IgG

不含载体蛋白

No

反应种属

Mouse, Rat, Human

应用

Flow Cyt (Intra), ICC/IF, WB, IP, IHC-P

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

特异性

This antibody detects Epidermal growth factor receptor (EGFR). It does not cross react with other ERBB family members. This product yielded a strong signal in western blot using A431 (human squamous carcinoma) lysate which naturally overexpresses the EGFR protein. Western blot conditions may need to be optimised for cell lines and tissues that express lower levels of endogenous EGFR.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/50", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p>This product yielded a strong signal in western blot using A431 (human squamous carcinoma) lysate which naturally overexpresses the EGFR protein. Western blot conditions may need to be optimised for cell lines and tissues that express lower levels of endogenous EGFR.</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/500", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/10 - 1/1000", "FlowCytIntra-species-notes": "<p><a href='/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>" }, "Mouse": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/200", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "Rat": { "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p>This product yielded a strong signal in western blot using A431 (human squamous carcinoma) lysate which naturally overexpresses the EGFR protein. Western blot conditions may need to be optimised for cell lines and tissues that express lower levels of endogenous EGFR.</p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

您可能对以下产品感兴趣:

AB269558

Human soluble EGFR ELISA Kit

0

0 Reviews

查看产品
为什么推荐这个?

我们推荐这个产品,因为它经常被用于相同的实验或相关的研究。

我们建议您务必查阅产品说明书,以确认其是否符合您的实验需求;若有疑问,也可联系我们的技术团队获取协助。

产品详情

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein A
存储溶液
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: 50% Glycerol (glycerin, glycerine), 49% PBS, 0.05% BSA
运输条件
Blue Ice
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Avoid freeze / thaw cycle

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

EGFR or Epidermal Growth Factor Receptor is a transmembrane glycoprotein that acts as a receptor for members of the epidermal growth factor family. Known alternatively as ErbB1 or HER1 this receptor has an approximate molecular weight of 170 kDa. EGFR is expressed in various cell types notably on epithelial cells and can influence multiple cellular processes through its kinase activity. It participates in the regulation of cell growth multiplication and survival by activating its kinase domain upon ligand binding.
Biological function summary

The EGFR protein plays an important role in cellular communication and signaling processes. EGFR pairs with other receptor family members to form active dimers or even higher-order complexes which in turn initiate intracellular signaling cascades. Through these complexes EGFR influences many processes including cell differentiation and repair. This function of EGFR makes it an integral part of mammalian biology affecting how cells respond to their environment by mediating changes in gene expression.

Pathways

EGFR is a central player in the MAPK and PI3K/Akt signaling pathways. Alongside other protein partners like KRAS and PI3 kinase it contributes to transmitting signals from the cell surface to the nucleus affecting gene transcription and cell behavior. These pathways are important for normal cell growth and division and aberrations in these pathways can lead to excessive or insufficient cell proliferation.

EGFR is pertinent to cancer biology including non-small cell lung cancer and glioblastoma where mutations or overexpression of the receptor frequently occur. It connects to proteins such as PTEN and BRAF which influence tumor progression and response to targeted therapies. EGFR's involvement in these disorders highlights its significance as a therapeutic target since it can be manipulated to alter disease progression.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

The protein expressed by the EGFR gene functions as a receptor tyrosine kinase, binding with ligands from the EGF family to activate several signaling cascades that translate extracellular signals into cellular responses. Known ligands include EGF, TGFA/TGF-alpha, AREG, epigen, BTC/betacellulin, epiregulin, and HBEGF. Ligand binding triggers receptor dimerization and autophosphorylation, recruiting adapter proteins like GRB2 and activating complex downstream signaling pathways such as RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC, and STATs, and possibly the NF-kappa-B cascade. EGFR also directly phosphorylates proteins like RGS16 and MUC1, influencing various cellular processes including its coupling with G protein-coupled receptor signaling and cell migration through interaction with CCDC88A/GIV. Isoform 2 of EGFR may act as an antagonist to EGF actions. In microbial infection, EGFR also serves as a receptor facilitating hepatitis C virus (HCV) entry into hepatocytes by promoting CD81-CLDN1 receptor complexes and enhancing membrane fusion with HCV envelope glycoproteins. This supplementary information is collated from multiple sources and compiled automatically.
See full target information EGFR

文献 (34)

Recent publications for all applications. Explore the full list and refine your search

ERJ open research 9: PubMed38152085

2023

Epithelial-mesenchymal transition changes in nonsmall cell lung cancer patients with early COPD.

Applications

Unspecified application

Species

Unspecified reactive species

Wenying Lu,Mathew Suji Eapen,Ashutosh Hardikar,Collin Chia,Iain Robertson,Gurpreet Kaur Singhera,Tillie L Hackett,Sukhwinder Singh Sohal

Biomedicines 11: PubMed38137419

2023

Rhamnetin Prevents Bradykinin-Induced Expression of Matrix Metalloproteinase-9 in Rat Brain Astrocytes by Suppressing Protein Kinase-Dependent AP-1 Activation.

Applications

Unspecified application

Species

Unspecified reactive species

Chuen-Mao Yang,I-Ta Lee,Li-Der Hsiao,Zih-Yao Yu,Chien-Chung Yang

Biology direct 18:33 PubMed37337223

2023

PSMD3-ILF3 signaling cascade drives lung cancer cell proliferation and migration.

Applications

Unspecified application

Species

Unspecified reactive species

Jin Zhang,Qianli Ma,Qiduo Yu,Fei Xiao,Zhenrong Zhang,Hongxiang Feng,Chaoyang Liang

MedComm 4:e237 PubMed37035133

2023

Targeted therapy for cisplatin-resistant lung cancer via aptamer-guided nano-zinc carriers containing USP14 siRNA.

Applications

Unspecified application

Species

Unspecified reactive species

Xinmin Zhao,Xianghua Wu,Huijie Wang,Songtao Lai,Jialei Wang

Cancers 15: PubMed36831558

2023

Integrin αvβ3 Is a Master Regulator of Resistance to TKI-Induced Ferroptosis in HER2-Positive Breast Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Aadya Nagpal,Kristen Needham,Darius J R Lane,Scott Ayton,Richard P Redvers,Melissa John,Heloisa S Selistre-de-Araujo,Delphine Denoyer,Normand Pouliot

Cells 12: PubMed36611882

2022

Human Placental Endothelial Cell and Trophoblast Heterogeneity and Differentiation Revealed by Single-Cell RNA Sequencing.

Applications

Unspecified application

Species

Unspecified reactive species

Han Li,Hao Peng,Wei Hong,Yingying Wei,Haojun Tian,Xiaojie Huang,Linyan Jia,Jing Zheng,Tao Duan,Qizhi He,Kai Wang

BMC cancer 22:1216 PubMed36434543

2022

Higher thymocyte selection-associated high mobility group box (TOX) expression predicts poor prognosis in patients with ovarian cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Sai Li,Sifu Yang,Yupeng Hong

Frontiers in endocrinology 13:971564 PubMed36440230

2022

Role of EGFR expressed on the granulosa cells in the pathogenesis of polycystic ovarian syndrome.

Applications

Unspecified application

Species

Unspecified reactive species

Jun-Hui Zhang,Lei Zhan,Ming-Ye Zhao,Jin-Juan Wang,Fen-Fen Xie,Zu-Ying Xu,Qian Xu,Yun-Xia Cao,Qi-Wei Liu

Development (Cambridge, England) 149: PubMed36205077

2022

A tumor-suppressive function for Notch3 in the parous mammary gland.

Applications

Unspecified application

Species

Unspecified reactive species

Wen-Cheng Chung,Sean E Egan,Keli Xu

Molecular therapy oncolytics 23:432-446 PubMed34853814

2021

Selective sodium iodide symporter () genetherapy of glioblastoma mediatedby EGFR-targeted lipopolyplexes.

Applications

Unspecified application

Species

Unspecified reactive species

Rebekka Spellerberg,Teoman Benli-Hoppe,Carolin Kitzberger,Simone Berger,Kathrin A Schmohl,Nathalie Schwenk,Hsi-Yu Yen,Christian Zach,Franz Schilling,Wolfgang A Weber,Roland E Kälin,Rainer Glass,Peter J Nelson,Ernst Wagner,Christine Spitzweg
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

关联产品

Select an associated product type
Alternative Product
Primary Antibodies

AB226993

Anti-EGFR (phospho Y974) antibody

primary-antibodies

egfr-phospho-y974-antibody-ab226993

0

(0 reviews)

Alternative Product
Primary Antibodies

AB227023

Anti-EGFR (phospho Y974) antibody

primary-antibodies

egfr-phospho-y974-antibody-ab227023

0

(0 reviews)

Alternative Product
Primary Antibodies

AB265799

Anti-EGFR antibody [AT2H8]

primary-antibodies

egfr-antibody-at2h8-ab265799

0

(0 reviews)

Alternative Product
Primary Antibodies

AB239309

PE/Cy7® Anti-EGFR antibody [EGFR1]

primary-antibodies

pe-cy7-egfr-antibody-egfr1-ab239309

0

(0 reviews)

Alternative Product
Primary Antibodies

AB81440

Anti-EGFR (phospho Y992) antibody [EM-12]

primary-antibodies

egfr-phospho-y992-antibody-em-12-ab81440

0

(0 reviews)

Alternative Product
Primary Antibodies

AB27764

PE Anti-EGFR antibody [ICR10]

primary-antibodies

pe-egfr-antibody-icr10-ab27764

0

(0 reviews)

Alternative Product
Primary Antibodies

AB231

Anti-EGFR antibody [ICR10]

primary-antibodies

egfr-antibody-icr10-ab231

4

(7 reviews)

Alternative Product
Primary Antibodies

AB11400

FITC Anti-EGFR antibody [ICR10]

primary-antibodies

fitc-egfr-antibody-icr10-ab11400

4

(1 reviews)

Alternative Product
Primary Antibodies

AB194756

Anti-EGFR (phospho Y845) antibody

primary-antibodies

egfr-phospho-y845-antibody-ab194756

0

(0 reviews)

Alternative Product
Primary Antibodies

AB8465

Anti-EGFR antibody [2E9]

primary-antibodies

egfr-antibody-2e9-ab8465

4

(2 reviews)

Alternative Product
Primary Antibodies

AB131498

Anti-EGFR antibody

primary-antibodies

egfr-antibody-ab131498

0

(0 reviews)

Alternative Product
Primary Antibodies

AB5638

Anti-EGFR (phospho Y992) antibody

primary-antibodies

egfr-phospho-y992-antibody-ab5638

0

(0 reviews)

Alternative Product
Primary Antibodies

AB5644

Anti-EGFR (phospho Y1068) antibody

primary-antibodies

egfr-phospho-y1068-antibody-ab5644

4

(5 reviews)

Alternative Product
Primary Antibodies

AB5650

Anti-EGFR (phospho Y1086) antibody

primary-antibodies

egfr-phospho-y1086-antibody-ab5650

4

(1 reviews)

Alternative Product
Primary Antibodies

AB5651

Anti-EGFR (phospho Y1148) antibody

primary-antibodies

egfr-phospho-y1148-antibody-ab5651

0

(0 reviews)

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com